tiprankstipranks
Advertisement
Advertisement
Biomea Fusion doses first patient in OPAL study
PremiumThe FlyBiomea Fusion doses first patient in OPAL study
19d ago
Citi adds ‘upside 90-day catalyst watch’ on Biomea into GLP-1 data
Premium
The Fly
Citi adds ‘upside 90-day catalyst watch’ on Biomea into GLP-1 data
25d ago
Biomea Fusion price target lowered to $7 from $9 at Citizens
Premium
The Fly
Biomea Fusion price target lowered to $7 from $9 at Citizens
29d ago
Biomea Labs: Buy Rating Reiterated as Icovamenib Data Strengthen Metabolic Disease Thesis; $4 Price Target Maintained
PremiumRatingsBiomea Labs: Buy Rating Reiterated as Icovamenib Data Strengthen Metabolic Disease Thesis; $4 Price Target Maintained
3M ago
Biomea Fusion management to meet with Citizens
Premium
The Fly
Biomea Fusion management to meet with Citizens
3M ago
Biomea Fusion partners with University of Leicester on obesity study
Premium
The Fly
Biomea Fusion partners with University of Leicester on obesity study
3M ago
Biomea Fusion initiated with an Outperform at Citizens
PremiumThe FlyBiomea Fusion initiated with an Outperform at Citizens
4M ago
Biomea Fusion options imply 22.0% move in share price post-earnings
Premium
The Fly
Biomea Fusion options imply 22.0% move in share price post-earnings
4M ago
Biomea Fusion Reports Positive Phase 2 T1D Trial Results
Premium
Company Announcements
Biomea Fusion Reports Positive Phase 2 T1D Trial Results
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100